Services-Commercial Physical & Biological Research
11 stocks in Healthcare & Pharma · SIC 8731.
Company snapshot 2026-11-13 · Calculated market cap as of 2026-11-06 · USD
| Ticker | Company | Market Cap | Revenue (TTM) | Net Income (TTM) |
|---|---|---|---|---|
| IQV | IQVIA HOLDINGS INC. | $43.65B | $17.31BTTM ended 2026-09-30 | $1.39BTTM ended 2026-09-30 |
| INCY | INCYTE CORP | $24.05B | $6.01BTTM ended 2026-09-30 | $403.41MTTM ended 2026-09-30 |
| MEDP | Medpace Holdings, Inc. | $17.76B | $2.84BTTM ended 2026-09-30 | $517.83MTTM ended 2026-09-30 |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $15.00B | $3.98BTTM ended 2026-09-26 | $40.19MTTM ended 2026-09-26 |
| ABSI | Absci Corp | $1.61B | $1.56MTTM ended 2026-06-30 | −$121.08MTTM ended 2026-06-30 |
| OABI | OmniAb, Inc. | $704.51M | $40.21MTTM ended 2026-09-30 | −$43.47MTTM ended 2026-09-30 |
| NRC | NRC HEALTH | $540.72M | $143.79MTTM ended 2026-09-30 | $9.04MTTM ended 2026-03-31 |
| MXCT | MAXCYTE, INC. | $135.20M | $31.05MTTM ended 2026-06-30 | −$35.64MTTM ended 2026-06-30 |
| ONMD | OneMedNet Corp | $24.72M | $1.46MTTM ended 2026-06-30 | −$8.51MTTM ended 2026-06-30 |
| BIAF | bioAffinity Technologies, Inc. | $21.06M | $5.53MTTM ended 2026-09-30 | −$15.41MTTM ended 2026-09-30 |
| ISPC | iSpecimen Inc. | $2.04M | $466.30KTTM ended 2026-06-30 | −$11.42MTTM ended 2026-06-30 |
No matching companies.